(1) Studies supporting massive transfusion protocols using fixed plasma to red blood cell ratios have significant survivor bias that neglect differences in patient severity. (2) Patients who received higher plasma ratios were less severely injured and coagulopathic on presentation. (3) Using point-of-care coagulation monitoring allows for a goal-directed, individualized approach to plasma transfusion that reduces unnecessary plasma use and risk of complications compared to fixed ratio strategies.